Original content from the Mapping Pathways blog team
“We need to ensure
access to all forms of prevention and treatment is readily and easily available
for anyone who needs it, so people can reduce their risk, get the prevention
and care they need, reduce onward transmission and lead healthy lives.”
Jessica Terlikowski is
director of regional organizing at AIDS
United based in Washington, D.C. and was most recently a policy manager at
the AIDS Foundation of Chicago. Both organizations
are Mapping Pathways partners. Jessica is co-founder of the Chicago Female
Condom Campaign, and coordinates the National Female Condom Coalition. She was
recently honored by the AIDS Legal Council
of Chicago as “Advocate of the year” for outstanding work
in making a difference in the lives of people with HIV and AIDS.
In part 1 of her
interview, Jessica discussed the importance of scaling up interventions we know
that work while moving forward with new strategies like PrEP. In part II of the
interview, she discusses some of the challenges that have to be overcome in the
HIV prevention landscape.
MP: In our previous
conversation, you mentioned a lack of political will to invest in resources?
Could you elaborate on that?
JT: In the United
States, there are a number of state and federal lawmakers who are proposing
deep cuts to health care, prevention, and other public assistance programs in
the name of “fiscal responsibility.” They claim that by reducing the
government’s spending on such programs, we can begin to turn the U.S. economy
around. However, such cuts would be devastating to those of us who already
struggle financially and have limited to no access to healthcare – the majority
of people with HIV. Additionally, decimating health and social safety net
programs results in higher future costs which simple doesn’t make good economic
sense.
Federal funding for syringe-exchange programs has recently
been banned
once more, just two years after our Congress lifted a 21-year ban. These programs
provide sterile syringes, male and female condoms, HIV and hepatitis counseling
and testing, vaccinations, and many other lifesaving services to injection-drug
users and their partners. Syringe
exchange is one of the most successful and cost-effective interventions we
have.
We’re in a situation now where we are getting conflicting
messages from our leaders. On the one hand, we have Secretary of State Hillary
Clinton saying, “we
can have an AIDS-free generation “, while at the same time Congress is
making decisions that undercut efforts to actually get us to that point.
MP: Why is the work
that Mapping Pathways is doing important right now?
JT: Our work
especially matters because we have a number of tools now and coming down the
pike to stem the HIV epidemic. We have several strategies at our disposal
including PrEP
and TLC+. While the stakeholder interviews and community input sessions are
hugely beneficial to us, they also inform, educate and create a discussion
among the stakeholders and the communities they belong to.
Many people’s knowledge of ARV-based prevention strategies
is limited. They also have a lot of questions and concerns. . We are creating a
space for people to learn and to discuss each of the options and how they
relate to each other. Mapping Pathways participants then communicate and
discuss the broader issues with their own communities. This is something that
we are working on now—the dissemination of the community and expert
perspectives we collected in the first year of the project.
Mapping Pathways is also important here in the U.S. because
HIV continues to be a big problem here that especially impacts people who are
already marginalized: people with low incomes, gay men, transgender women and
women of color, people who use drugs. These are communities whose needs must be
prioritized if we are to reduce the number of new HIV infections.
Mapping Pathways is all about having conversations about ARV-based
prevention strategies. We need to make sure that these strategies are not going
to be reserved just for people who already have access to healthcare. We need to ensure access to all forms of
prevention and treatment is readily and easily available for anyone who needs
it, so people can reduce their risk, get the prevention and care they need,
reduce onward transmission and lead healthy lives.
MP: Is this possible
in the U.S. context right now?
JT: It is, but it
won’t happen overnight. AIDS is a social justice issue and not just a public
health issue. We have to talk about many other issues when we talk about HIV,
like sex, drugs, and poverty, which are not things many people feel comfortable
talking about. Our job as advocates is to raise these issues with decision makers
and educate and organize our communities to build the necessary political will.
MP: What is the most
satisfying part of your job?
JT: I think the
most satisfying part of my job is working with others who share a common
passion and drive on these issues. We are all deeply committed to working with
our communities to increase political will for greater investment in and
attention on HIV prevention, treatment, and care issues.
Read the first part of
Jessica’s interview here, and learn more about the Mapping Pathways learnings
from the U.S. here.
[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position. Please look for us on Facebook here www.facebook.com/MappingPathways and you can follow us on Twitter @mappingpathways as well.]
No comments:
Post a Comment